Adding nivolumab to neoadjuvant chemo improves response rate for high risk ER+ HER2− breast cancer

Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer

Belzutifan improves PFS, ORR in clear cell renal cell carcinoma

Effects of short-term fasting on quality of life as an add-on option during chemotherapy

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for ccRCC

Genomic testing: Awareness and effective communication between healthcare professionals and patients

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC

Durvalumab addition to chemo shows endometrial cancer benefit

Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC

Selpercatinib benefit for advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer

CheckMate-77T: Perioperative nivolumab benefit for NSCLC